PAP

Persistent Asset Partners Portfolio holdings

AUM $114M
This Quarter Return
+1.61%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$117M
AUM Growth
Cap. Flow
+$117M
Cap. Flow %
100%
Top 10 Hldgs %
43.37%
Holding
124
New
96
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 70%
2 Financials 24.42%
3 Energy 2.02%
4 Materials 1.9%
5 Consumer Discretionary 1.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BBIO icon
101
BridgeBio Pharma
BBIO
$9.91B
0
BMEA icon
102
Biomea Fusion
BMEA
$114M
0
CAPR icon
103
Capricor Therapeutics
CAPR
$287M
0
CLDX icon
104
Celldex Therapeutics
CLDX
$1.57B
0
COIN icon
105
Coinbase
COIN
$77.7B
0
CORT icon
106
Corcept Therapeutics
CORT
$7.52B
0
FOLD icon
107
Amicus Therapeutics
FOLD
$2.42B
0
HALO icon
108
Halozyme
HALO
$8.75B
0
JANX icon
109
Janux Therapeutics
JANX
$1.38B
0
KOD icon
110
Kodiak Sciences
KOD
$453M
0
KRE icon
111
SPDR S&P Regional Banking ETF
KRE
$3.97B
0
KROS icon
112
Keros Therapeutics
KROS
$640M
0
LXRX icon
113
Lexicon Pharmaceuticals
LXRX
$392M
0
MRNA icon
114
Moderna
MRNA
$9.36B
0
NVO icon
115
Novo Nordisk
NVO
$252B
0
OCUL icon
116
Ocular Therapeutix
OCUL
$2.25B
0
RARE icon
117
Ultragenyx Pharmaceutical
RARE
$3.04B
0
RXRX icon
118
Recursion Pharmaceuticals
RXRX
$2.02B
0
SAVA icon
119
Cassava Sciences
SAVA
$107M
0
SMMT icon
120
Summit Therapeutics
SMMT
$17.5B
0
SPY icon
121
SPDR S&P 500 ETF Trust
SPY
$656B
0
UBX
122
DELISTED
Unity Biotechnology
UBX
0
VERV
123
DELISTED
Verve Therapeutics
VERV
0
VLY icon
124
Valley National Bancorp
VLY
$5.88B
0